US researchers develop new vaccine that blocks COVID-19, variants, other viruses
New York: US researchers have developed a potential new vaccine, which has proven effective against the original SARS-CoV-1, SARS-CoV-2 as ...
New York: US researchers have developed a potential new vaccine, which has proven effective against the original SARS-CoV-1, SARS-CoV-2 as ...
London: After the news broke that 23 elderly patients died in Norway following their immunization with the Pfizer-BioNTech mRNA vaccine ...
SRINAGAR: Over 70 top doctors and head of departments (HODs) have volunteered to take the first shot of the Covid ...
Srinagar: The first batch of COVID-19 vaccine reached Srinagar today afternoon with officials saying that the first dose will be given ...
The Drugs Controller General of India (DCGI) on Sunday approved Covaxin and Covishield for restricted emergency use. While making the ...
As India gears up to launch the world's largest immunisation drive, Union health minister Harsh Vardhan urged the public not ...
Terming the approval for Oxford-AstraZeneca vaccine for use in the United Kingdom as a 'big step forward', All India Institute ...
India is the largest buyer of COVID-19 vaccines in the world with 1.6 billion doses, according to a global analysis, ...
JAMMU: The Chief Secretary, B V R Subrahmanyam today chaired a marathon meeting with Deputy Commissioners of all the districts ...
London: In a historic move, Britain has become the first country in the world to approve the Pfizer-BioNTech coronavirus vaccine. ...
10Cric is considered to be the home of online betting in India! Visit 10cric.com/online-betting/ and get the best odds on all major sports, directly on your mobile.
Copyright © 1996 - 2022 - All rights reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Monitor.
Copyright © 1996 - 2022 - All rights reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Monitor.